Original Research

Published on 31 Jan 2024

Radiomic model based on magnetic resonance imaging for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer patients

in Breast Cancer

Yimiao Yu
Zhibo Wang
Qi Wang
Xiaohui Su
Zhenghao Li
Ruifeng Wang
Tianhui Guo
Wen Gao
Haiji Wang
Biyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1249339

1,400 views

Review

Published on 29 Jan 2024

MyD88 signaling pathways: role in breast cancer

in Breast Cancer

Hongmei Zheng
Xinhong Wu
Liantao Guo
Jianhua Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1336696

1,957 views

Review

Published on 26 Jan 2024

Patient-derived organoids: a promising tool for breast cancer research

in Breast Cancer

Yixin Shi
Zhanwen Guan
Gengxi Cai
Yichu Nie
Chuling Zhang
Wei Luo
Jia Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1350935

2,529 views
1 citation

Review

Published on 25 Jan 2024

mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation

in Breast Cancer

Ye Hu
Fengxi Chen
Siwen Sun
Lingzhi Xv
Xueqing Wang
Meiling Wang
Shanshan Zhao
Zuowei Zhao
Man Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1312634

2,393 views
1 citation

Original Research

Published on 24 Jan 2024

Prognostic analysis of cT1-3N1M0 breast cancer patients who have responded to neoadjuvant therapy undergoing various axillary surgery and breast surgery based on propensity score matching and competitive risk model

in Breast Cancer

Maoquan Zhang
Yingming Sun
Huasheng Wu
Jian Xiao
Wenxin Chen
Hebin Wang
Binglin Yang
Huatian Luo

Frontiers in Oncology

doi 10.3389/fonc.2024.1319981

1,263 views
1 citation

Original Research

Published on 24 Jan 2024

A Mendelian analysis of the relationships between immune cells and breast cancer

in Breast Cancer

Xin Wang
Haoyu Gao
Yiyao Zeng
Jie Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1341292

4,586 views
3 citations

Original Research

Published on 24 Jan 2024

Breast cancer but not the menopausal status is associated with small changes of the gut microbiota

in Breast Cancer

Natalia Zeber-Lubecka
Maria Kulecka
Agnieszka Jagiełło-Gruszfeld
Michalina Dąbrowska
Anna Kluska
Magdalena Piątkowska
Katarzyna Bagińska
Maria Głowienka
Piotr Surynt
Michał Tenderenda

Frontiers in Oncology

doi 10.3389/fonc.2024.1279132

1,495 views
2 citations

Original Research

Published on 24 Jan 2024

Monitoring response to neoadjuvant therapy for breast cancer in all treatment phases using an ultrasound deep learning model

in Breast Cancer

Jingwen Zhang
Jingwen Deng
Jin Huang
Liye Mei
Ni Liao
Feng Yao
Cheng Lei
Shengrong Sun
Yimin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1255618

1,088 views

Case Report

Published on 23 Jan 2024

Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole: a case report and literature review

in Breast Cancer

Nuno Rodrigues Alves
Ana Filipa Duarte
David Fernandes Ribeiro
Rita Sousa Silva
Bruno Almeida Carvalho
Diogo Alpuim Costa

Frontiers in Oncology

doi 10.3389/fonc.2024.1286910

1,872 views

Correction

Published on 23 Jan 2024

Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions

in Breast Cancer

Daniele Generali
Rossana Berardi
Michele Caruso
Marina Cazzaniga
Ornella Garrone
Ida Minchella
Ida Paris
Carmine Pinto
Sabino De Placido

Frontiers in Oncology

doi 10.3389/fonc.2024.1369562

517 views

Case Report

Published on 19 Jan 2024

Case report: The first case of concurrent breast myeloid sarcoma and borderline phyllodes tumor with malignant features

in Breast Cancer

Li Chun
Zhen Zeng
Qianyu Guo
Yangjun He

Frontiers in Oncology

doi 10.3389/fonc.2023.1268617

1,047 views

Case Report

Published on 18 Jan 2024

Case report: Urothelial injury in a female with breast cancer: a rare adverse event after the combination of paclitaxel and trastuzumab

in Breast Cancer

Tinghua Cao
Zhipei Duan
Jing Zhu
Jing Wu
Jun Chen
Mingjun Jiang
Xialiang Lu
Yan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1258474

1,174 views

Review

Published on 16 Jan 2024

Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer

in Breast Cancer

Cui Zhang
Fulin Zhou
Jiali Zou
Yanman Fang
Yuncong Liu
Libo Li
Jing Hou
Guanghui Wang
Hua Wang
Xiaolian Lai

Frontiers in Oncology

doi 10.3389/fonc.2023.1322078

2,576 views

Case Report

Published on 15 Jan 2024

Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV triple-negative breast cancer with liver and bone marrow failure

in Breast Cancer

Bryan Chan
Jin Sun Lee
Yuan Yuan

Frontiers in Oncology

doi 10.3389/fonc.2023.1305584

1,262 views
1 citation

Case Report

Published on 12 Jan 2024

Bilateral inflammatory recurrence of HER-2 positive breast cancer: a unique case report and literature review

in Breast Cancer

Rong Qin
Xiangyang Wang
Tingting Fan
Ting Wu
Chao Lu
Xun Shao
Liang Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1276637

1,698 views

Original Research

Published on 10 Jan 2024

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy

in Breast Cancer

Silvia Mihaela Ilie
Nathalie Briot
Guillaume Constatin
Alis Ilie
Francoise Beltjens
Sylvain Ladoire
Isabelle Desmoulins
Audrey Hennequin
Aurelie Bertaut
Charles Coutant

Frontiers in Oncology

doi 10.3389/fonc.2023.1309890

1,563 views
1 citation

Navigation group

Articles

Radiomic model based on magnetic resonance imaging for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer patients

MyD88 signaling pathways: role in breast cancer

Patient-derived organoids: a promising tool for breast cancer research

mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation

Prognostic analysis of cT1-3N1M0 breast cancer patients who have responded to neoadjuvant therapy undergoing various axillary surgery and breast surgery based on propensity score matching and competitive risk model

A Mendelian analysis of the relationships between immune cells and breast cancer

Breast cancer but not the menopausal status is associated with small changes of the gut microbiota

Monitoring response to neoadjuvant therapy for breast cancer in all treatment phases using an ultrasound deep learning model

Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole: a case report and literature review

Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions

Case report: The first case of concurrent breast myeloid sarcoma and borderline phyllodes tumor with malignant features

Case report: Urothelial injury in a female with breast cancer: a rare adverse event after the combination of paclitaxel and trastuzumab

Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer

Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV triple-negative breast cancer with liver and bone marrow failure

Bilateral inflammatory recurrence of HER-2 positive breast cancer: a unique case report and literature review

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy